Introduction
Whole body energy homeostasis is regulated in part by nutrient-sensing members of the nuclear hormone receptor superfamily of ligand-dependent transcription factors, such as the peroxisome proliferator-activated receptor alpha (PPAR). Like other nuclear hormone receptors, the PPAR protein is comprised of several distinct domains, including a highly conserved DNA binding domain (DBD) and a less conserved C-terminal ligand binding domain (LBD). In highly metabolic tissues such as liver and heart, PPAR heterodimerizes with the retinoid X receptor alpha (RXR, and this heterodimer potently activates genes involved in fatty acid oxidation (1) (2) (3) . At a cellular level PPAR regulates fatty acid metabolism, glucose metabolism, inflammation, differentiation, and proliferation (4) (5) (6) .
Although a multitude of exogenous ligands have been shown to activate both human and mouse PPAR (1, (7) (8) (9) , the identity of high-affinity endogenous ligands has been more elusive.
Studies utilizing recombinant PPAR proteins have largely focused on the ligand binding domain of mouse PPAR (mPPAR). These studies suggest that long-chain fatty acids (LCFA) and their activated metabolites (long-chain acyl-CoAs, LCFA-CoA) may function as endogenous 5 difference may exist. Administration of PPAR agonists (e.g. Wy-14,643) to rodents results in peroxisome proliferation and hepatic cancer -effects not observed in humans (16). Even though human and mouse PPAR proteins share 91% identity (17), the observed physiological responses to exogenous activators suggest that minor sequence differences may be important to PPAR function.
The objective of the current study was to elucidate whether LCFA and/or LCFA-CoA constitute high-affinity endogenous ligands for full-length hPPAR and to determine if species differences affect ligand specificity. Since elevated LCFA are associated with metabolic, endocrine, and cardiovascular complications, these data are important for understanding the molecular role of dietary nutrients in PPAR mediated energy homeostasis. As putative ligands of PPAR, LCFA and/or LCFA-CoA may control their own metabolism by binding PPAR and inducing PPAR regulated genes important for fatty acid uptake, transport, and oxidation. Thus, dysregulated LCFA could alter the transcriptional activity of PPAR leading to hyper-or hypoactivation of these genes and further contributing to the metabolic imbalance. and a one-way ANOVA was used to evaluate overall significance. A Fisher Least Significant difference (LSD) post-hoc test was used to identify individual group differences. The results are presented as mean ± SEM. The confidence limit of p < 0.05 was considered statistically significant.
Materials and Methods

Chemicals
Results
Full-length hPPAR and mPPAR protein purification:
Based on recent demonstrations that truncation of a nuclear transcription factor can significantly affect ligand binding affinity, specificity, and consequently receptor activity (23, 24), full-length hPPAR and mPPAR were used for all experiments. SDS-PAGE and Coomassie blue staining indicated predominant bands of 52 kDa corresponding to the expected size of full-length hPPAR and mPPAR, for which densitometry indicated greater than 85% purity ( Fig. 1A and 1B) . Western blotting confirmed that the predominant protein bands were PPAR (Fig. 1C) . Although these data were consistent with previous data suggesting that a truncated mPPAR protein can bind to both BODIPY C16 fatty acid derivative and BODIPY C16-CoA with high affinity (19), these data also suggested that species differences exist in ligand binding specificity. Fig. 1 ). Quantitative analyses of these data suggested strong affinity binding (K i = 10-40 nM, Table I ). By comparison, the synthetic PPAR agonist clofibrate showed slightly weaker affinity (K i = 48 nM), while the synthetic PPAR agonist rosiglitazone showed no displacement (Table I ). These data revealed that both LCFA and LCFA-CoA are capable of displacing a fluorescent fatty acyl-CoA, suggesting that both LCFA and LCFA-CoA could be endogenous ligands of hPPAR. These data are in contrast with displacement studies conducted with a truncated form of mPPAR, which showed that only unsaturated LCFA, but not saturated LCFA, could displace a bound fluorescent fatty acid (11), and suggest that important differences may exist between hPPAR and mPPAR. Table II ) for mPPAR. The mPPAR showed similar displacement and affinity for the synthetic PPAR agonist clofibrate (K i = 46 nM, Table II ) as compared hPPAR (Table I) , and the synthetic PPAR agonist rosiglitazone showed no displacement (Table II) . These data show that LCFA and LCFA-CoA are both capable of displacing a fluorescent fatty acyl-CoA, suggesting that both LCFA and LCFA-CoA could be endogenous ligands of mPPAR. When compared to binding data from hPPAR (Table I) , these data also suggest differences in the ligand binding specificity between hPPAR and mPPAR, particularly for saturated LCFA. (Table I) , similar to affinities determined by displacement assays. Titration with lauric acid (Fig. 3I ) and lauryl-CoA ( Fig. 3J ) did not significantly alter hPPAR fluorescence, and no binding was detected (Table I ). The PPAR agonist clofibrate strongly quenched hPPAR fluorescence (Fig. 3K ), but displayed weaker affinity than the LCFA (Table I) , while the PPAR agonist rosiglitazone showed no binding ( (Fig. 4K) . Although the weak binding of palmitic acid and stearic acid to full-length mPPAR was consistent with previous data using mPPARAB, it was significantly different from the binding of hPPAR with the same ligand (Table I) . On the other hand, while mPPARAB demonstrated weak binding towards polyunsaturated fatty acids (PUFA), such as eicosapentanoic acid and docosahexaenoic acid, our data employing full-length mPPAR and hPPAR demonstrated high-affinity binding for both these PUFA (Fig. 4D, 3D , Table I and   Table II ). These findings suggest two important conclusions. There exist species dependent differences in the ligand binding specificity and affinity between human and mouse PPAR, and the N-terminal domain of PPAR plays an unexpected, but important, role in the ligand binding function of the protein.
Binding of endogenous
Effect of endogenous fatty acids and fatty acyl-CoAs on hPPAR secondary structure:
Ligand-activated receptors, such as PPAR, undergo conformational changes upon ligand binding, which allows for altered co-factor interactions (12, 25, 26). Circular dichroism was used to examine whether the binding of LCFA or LCFA-CoA altered the hPPARα secondary structure. The far UV circular dichroic spectrum of hPPAR suggested the presence of substantial -helical content, exhibiting a large positive peak at 192 nm and two negative peaks at 207 and 222 nm (Fig. 5A-F, filled circles) . Quantitative analyses of the circular dichroic spectra confirmed that hPPAR was composed of approximately 32 % -helix, 18 % β-sheets, 21 % β-turns and 29 % unordered structures (Table III) .
Since most of the examined ligands were shown to bind at a single binding site, ligand (Table III) . However, lauric acid and its CoA thioester, which showed no binding, resulted in only minor, non-significant changes to the hPPAR secondary structure (Fig. 5A , Table III ). Contrary to previously published mPPAR data (12, 13), the strongest conformational changes were noted with palmitic acid, stearic acid, eicosapentaenoic acid, and docosahexaenoic acid (Fig. 5 , Table III ). These changes in spectra and percent composition were stronger than those observed with the addition of clofibrate ( 5F, open circles, Table III) , and no changes were observed with the addition of rosiglitazone (Fig. 5F , filled triangles, Table III) , consistent with the decreased affinity of hPPAR for these compounds.
Effect of endogenous fatty acids and fatty acyl-CoAs on mPPAR secondary structure:
Consistent with hPPARthe far UV circular dichroic spectrum of mPPAR suggested the presence of substantial -helical content, exhibiting a large positive peak at 192 nm and two negative peaks at 207 and 222 nm (Fig. 6A-F, filled circles) . Quantitative analyses of the circular dichroic spectra confirmed that mPPAR was composed of approximately 30 % -helix,
19 % β-sheets, 22 % β-turns, and 29 % unordered structures (Table IV) , similar to hPPAR (Table III) . With the exception of lauric acid and lauryl-CoA (Fig. 6A ), the addition of fatty acids ( Fig. 6B -E, open circles) and fatty acyl-CoA ( (Table IV) , a trend similar to that seen with hPPAR. However, for several ligands the magnitude of the change was different between the two proteins. While palmitic acid and stearic acid resulted in some of the strongest changes to the hPPAR structure, addition of these same ligands resulted in some of the weakest changes seen to the mPPAR structure. Moreover, clofibrate had the strongest effect on mPPAR secondary structure and a very small effect on hPPAR secondary structure. The changes in circular dichroic spectra and estimated percent composition were consistent with the (Fig. 7A) . These data further validated LCFA or their metabolites as endogenous ligands of hPPAR needed to induce PPAR activity. However, addition of only the examined unsaturated LCFA and clofibrate significantly increased activity levels in COS-7 cells overexpressing mPPAR and mRXR (Fig. 7B ). The addition of the palmitic acid and stearic acid resulted in no significant changes in activity (Fig. 7B) , consistent with the weak binding affinity of mPPAR for these ligands. In addition to suggesting that LCFA and LCFA-CoA represent high-affinity ligands for mPPAR, these data also suggested that differences in binding affinity for saturated LCFA could significantly affect the activity of PPAR.
Discussion:
Although lipids have been shown to be endogenous ligands of PPAR from several species, including mouse, studies with hPPAR have focused on exogenous ligands. Since an increasing number of studies suggest species differences exist for ligand specificity and affinity Apart from identifying LCFA and LCFA-CoA as physiologically relevant endogenous ligands for hPPAR, these data highlight important species differences with respect to ligand specificity and affinity. While affinities for LCFA-CoA and unsaturated LCFA were similar between full-length human and murine PPAR, mPPAR only weakly bound the saturated palmitic acid and stearic acid, yet hPPAR strongly bound both. Similarly, some of the strongest changes in hPPAR secondary structure occurred with the addition of saturated and polyunsaturated LCFA, whereas saturated LCFA had only minor effects on mPPAR secondary structure. Consistent with these data, COS-7 cells overexpressing mPPAR and mRXR treated with these saturated LCFA did not transactivate the ACOX-PPRE-luciferase reporter at the examined concentrations, while unsaturated LCFA did. Taken together, these data suggested that the human and mouse PPAR proteins bind and respond differently to specific ligands.
Given the high evolutionary rate exhibited by PPAR (33), it is not surprising to see such differences between hPPAR and mPPAR. In addition, strong physiological differences exist between human and rodent PPAR activation. Long-term administration of PPAR agonists are associated with hepatic carcinomas in rodents, but "humanized" PPAR mice are resistant to PPAR agonist induced hepatocellular adenomas and carcinomas (16, 34). The potency and efficacy of many hypolipidemic agents and phthalate monoesters on the activation of human and mouse PPAR are also different (9, 14, 15). As previous microarray experiments have demonstrated a strong divergence between PPAR regulated genes in mouse and human hepatocytes (15), it is likely that a combination of ligand binding differences and target gene differences are responsible for the overall physiological variations. Other factors, including differences in ligand uptake and ligand metabolism between cell types, may account for some of these differences as well. However, this same study showed a high conservation in PPAR regulation of genes involved in lipid metabolism (15), suggesting that differences in these processes must be due to another mechanism -not just variation in target genes. Since a single mutation in the mouse PPAR ligand binding domain (E282G) results in altered activity but displays similar DNA binding capacity, protein levels, and protein localization (35), it suggests that individual amino acid differences in the ligand binding domain can affect activity through ligand binding. Such differences in specificity of mouse and human PPAR for specific nutrients could reflect an adaptation to different physiological and/or nutritional patterns of the species.
Additionally, these data suggest that differences exist in the binding affinity of full-length versus truncated PPAR. Data presented herein indicate that both full-length hPPAR and mPPAR bound polyunsaturated LCFA with strong affinity. This data challenges previously published data indicating that mouse PPAR does not bind saturated LCFA in the physiological range, and only weakly interacts with PUFA (11-13). While such differences may exist due to variations in protein preparation, ligand binding techniques, or changes in the protein's secondary structure, it should be noted that the previously published data was generated using a Table III . Effect of ligands on the relative proportion of hPPAR secondary structure determined by CD. These structures were as follows: total helices (H; a sum of regular α-helices and distorted α-helices), total sheets (S; a sum of regular β-sheets and distorted β-sheets), turns (Trn; β-turns), and unordered (Unrd) structures. Average Total H ± S.E. Total S ± S.E. Trn ± S.E. Unrd ± S.E. Table IV . Effect of ligands on the relative proportion of mPPAR secondary structure determined by CD. These structures were as follows: total helices (H; a sum of regular α-helices and distorted α-helices), total sheets (S; a sum of regular β-sheets and distorted β-sheets), turns (Trn; β-turns), and unordered (Unrd) structures. Average Total H ± S.E. Total S ± S.E. Trn ± S.E. Unrd ± S.E. 25.5±3.5 23±2 Asterisks represent significant differences between mPPAR only and mPPAR in the presence of added ligand (* P < 0.05, ** P < 0.001).
